The SME IPO of Medicamen Organics commenced its subscription on Friday and is scheduled to conclude on June 24. The company intends to raise approximately Rs 10.54 crore through this offering. Once successfully subscribed, the shares will be listed on the BSE SME platform.
The impact of the jobs report on U.S. rate cut prospects also raised the stakes for consumer price figures on Wednesday where any rise in
Tata Group’s non-banking arm Tata Capital ($300 million), Prem Watsa-backed IIFL Finance ($300 million) and Anil Agarwal’s Vedanta Resources ($500 million) are ready to hit
Advertiser Disclosure
Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.
Disclaimer
It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information
Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003